Individualized Neoantigen Therapy with Unusual Radiotherapy Enhancement (iNATURE)

NCT06314087 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Advanced Tumors

Interventions

OTHER: Placebo + conventional treatment including radiotherapy
COMBINATION_PRODUCT: Radiation: Radiation Therapy；Biological: Personalized tumor peptide vaccine

Sponsor

The University of Hong Kong-Shenzhen Hospital